The Chinese covid-19 vaccine candidate – BBIBP-corvi – which is likely to completely inactivate the SARS-cov-2 virus, is safe and receives an antibody response, according to a study published in The Lancet. Similar results were reported in a previous clinical trial for a different vaccine based on the inactivated whole …
Read More »China’s Covid-19 is safe, antibody responds: Lancet
